Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NOVO-B
Rang in aandelen #107
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Aandeelprijs
$41.14
Laatst gesynchroniseerd: 2026-09-21
Marktkapitalisatie
$182.76B
Verandering (1 dag)
-7.78%
Verandering (1 jaar)
-32.24%
Land
DK
Handel Novo Nordisk A/S (NOVO-B)

Categorie

EPS voor Novo Nordisk A/S (NOVO-B)
EPS per June 2026 TTM: $4.16
Volgens de laatste financiële rapporten en de aandelenkoers van Novo Nordisk A/S is de huidige EPS van het bedrijf (TTM) $4.16. Eind 2024 had het bedrijf een EPS van $3.16, een stijging ten opzichte van de EPS van 2023 die $2.76 bedroeg.
EPS-geschiedenis van Novo Nordisk A/S van 2000 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
2026 (TTM) $4.16 15.04%
2025 $3.62 14.52%
2024 $3.16 14.42%
2023 $2.76 56.72%
2022 $1.76 10.96%
2021 $1.59 7.30%
2020 $1.48 20.24%
2019 $1.23 0.54%
2018 $1.23 -1.37%
2017 $1.24 16.81%
2016 $1.06 7.67%
2015 $0.99 20.28%
2014 $0.82 -5.24%
2013 $0.87 25.34%
2012 $0.69 31.26%
2011 $0.53 18.44%
2010 $0.44 28.33%
2009 $0.35 18.86%
2008 $0.29 9.87%
2007 $0.27 50.37%
2006 $0.18 25.27%
2005 $0.14 2.77%
2004 $0.14 13.97%
2003 $0.12 44.42%
2002 $0.08 24.70%
2001 $0.07 19.07%
2000 $0.06 0.00%
EPS van vergelijkbare bedrijven of concurrenten
Bedrijf EPS EPS-verschil Land
$29.85 616.76%
US
$8.65 107.70%
US
$3.55 -14.76%
US
$20.39 389.58%
CH
$1.26 -69.74%
US